Biohaven Ltd (BHVN) - News Archive

: As bio-pharmaceutical companies navigate complex regulatory landscapes and the unpredictable waters of the securities market, instances of legal action against them remain significant touchpoints for industry stakehol...

Investor Alert: Biohaven Ltd. Faces Class Action Lawsuit Amid Declining Revenue and Market Challenges In a significant development for investors and stakeholders, Holzer & Holzer, LLC has released an investor alert conc...

The pharmaceutical industry is frequently characterized by its volatility and the complexities surrounding financial performance and regulatory compliance. A recent class action lawsuit filed against Biohaven Ltd. highl...

: This article provides an analysis of recent legal developments involving Biohaven Ltd., a pharmaceutical company embroiled in securities class actions. Two prominent law firms, Rosen Law Firm and Pomerantz LLP, are re...

Biohaven Ltd. Investors Urged to Act: September Deadline Approaches Amid Declining Financial Health In a significant development for Biohaven Ltd. (NYSE: BHVN) investors, renowned global investor rights law firm Rosen L...

In a significant development for the biotechnology sector, Pomerantz Law Firm has announced an investigation into Biohaven Ltd (NYSE: BHVN), a prominent player in the pharmaceutical industry. This inquiry has caught the...